Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Journal of Medicinal Chemistry
|
January 1, 1991
Novel 5-HT3 antagonists. Indole oxadiazoles
C J Swain, R Baker, C Kneen, et al.
Journal of Medicinal Chemistry
|
March 20, 1992
Novel 5-HT3 antagonists: indol-3-ylspiro(azabicycloalkane-3,5'(4'H)-oxazoles)
C J Swain, R Baker, C Kneen, et al.
Neuroscience
|
February 2, 2002
Chronic substance P (NK1) receptor antagonist and conventional antidepressant treatment increases burst firing of monoamine neurones in the locus coeruleus
K A Maubach, K Martin, G Chicchi, et al.
Journal of Medicinal Chemistry
|
April 29, 1994
Identification of L-tryptophan derivatives with potent and selective antagonist activity at the NK1 receptor
A M MacLeod, K J Merchant, F Brookfield, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 21, 2001
2-Aryl indole NK(1) antagonists: optimisation of the amide substituent
D Shaw, G G Chicchi, J M Elliott, et al.
The Journal of Biological Chemistry
|
March 4, 1994
Characterization of the interaction of N-acyl-L-tryptophan benzyl ester neurokinin antagonists with the human neurokinin-1 receptor
M A Cascieri, A M Macleod, D Underwood, et al.
Molecular Pharmacology
|
April 1, 1995
Characterization of the interaction of diacylpiperazine antagonists with the human neurokinin-1 receptor: identification of a common binding site for structurally dissimilar antagonists
M A Cascieri, L L Shiao, S G Mills, et al.
Journal of Medicinal Chemistry
|
November 24, 1995
Identification of a series of 3-(benzyloxy)-1-azabicyclo[2.2.2]octane human NK1 antagonists
C J Swain, E M Seward, M A Cascieri, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 17, 2001
2-Aryl indole NK1 receptor antagonists: optimisation of the 2-aryl ring and the indole nitrogen substituent
K Dinnell, G G Chicchi, M J Dhar, et al.
Journal of Medicinal Chemistry
|
November 16, 2001
An orally active, water-soluble neurokinin-1 receptor antagonist suitable for both intravenous and oral clinical administration
T Harrison, A P Owens, B J Williams, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Journal of Medicinal Chemistry
|
January 1, 1991
Novel 5-HT3 antagonists. Indole oxadiazoles
C J Swain, R Baker, C Kneen, et al.
Journal of Medicinal Chemistry
|
March 20, 1992
Novel 5-HT3 antagonists: indol-3-ylspiro(azabicycloalkane-3,5'(4'H)-oxazoles)
C J Swain, R Baker, C Kneen, et al.
Neuroscience
|
February 2, 2002
Chronic substance P (NK1) receptor antagonist and conventional antidepressant treatment increases burst firing of monoamine neurones in the locus coeruleus
K A Maubach, K Martin, G Chicchi, et al.
Journal of Medicinal Chemistry
|
April 29, 1994
Identification of L-tryptophan derivatives with potent and selective antagonist activity at the NK1 receptor
A M MacLeod, K J Merchant, F Brookfield, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 21, 2001
2-Aryl indole NK(1) antagonists: optimisation of the amide substituent
D Shaw, G G Chicchi, J M Elliott, et al.
The Journal of Biological Chemistry
|
March 4, 1994
Characterization of the interaction of N-acyl-L-tryptophan benzyl ester neurokinin antagonists with the human neurokinin-1 receptor
M A Cascieri, A M Macleod, D Underwood, et al.
Molecular Pharmacology
|
April 1, 1995
Characterization of the interaction of diacylpiperazine antagonists with the human neurokinin-1 receptor: identification of a common binding site for structurally dissimilar antagonists
M A Cascieri, L L Shiao, S G Mills, et al.
Journal of Medicinal Chemistry
|
November 24, 1995
Identification of a series of 3-(benzyloxy)-1-azabicyclo[2.2.2]octane human NK1 antagonists
C J Swain, E M Seward, M A Cascieri, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 17, 2001
2-Aryl indole NK1 receptor antagonists: optimisation of the 2-aryl ring and the indole nitrogen substituent
K Dinnell, G G Chicchi, M J Dhar, et al.
Journal of Medicinal Chemistry
|
November 16, 2001
An orally active, water-soluble neurokinin-1 receptor antagonist suitable for both intravenous and oral clinical administration
T Harrison, A P Owens, B J Williams, et al.
Page
of 3